These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Phase 0 trials: are they ethically challenged? Hill TP Clin Cancer Res; 2007 Feb; 13(3):783-4. PubMed ID: 17289866 [No Abstract] [Full Text] [Related]
27. [Pharmacological research and pregnancy]. Dirix P Rev Med Brux; 2001 Sep; 22(4):A257-9. PubMed ID: 11680184 [TBL] [Abstract][Full Text] [Related]
28. [Assessment of group composition in clinical studies with reference to ethical aspects]. Hiller E Z Arztl Fortbild (Jena); 1990; 84(7):343-5. PubMed ID: 2378113 [No Abstract] [Full Text] [Related]
29. Recommended guidelines for studies of human subjects with spinal cord injury. Anderson DK; Beattie M; Blesch A; Bresnahan J; Bunge M; Dietrich D; Dietz V; Dobkin B; Fawcett J; Fehlings M; Fischer I; Grossman R; Guest J; Hagg T; Hall ED; Houle J; Kleitman N; McDonald J; Murray M; Privat A; Reier P; Steeves J; Steward O; Tetzlaff W; Tuszynski MH; Waxman SG; Whittemore S; Wolpaw J; Young W; Zheng B Spinal Cord; 2005 Aug; 43(8):453-8. PubMed ID: 15824756 [No Abstract] [Full Text] [Related]
30. [The clinical trial for only one patient. Justification, methodology and bioethical remarks]. Cabello López JB; Abraira V; Gómez García J Med Clin (Barc); 1997 Nov; 109(15):592-8. PubMed ID: 9441196 [No Abstract] [Full Text] [Related]
31. [Planning clinical trials and observing ethical principles from the biometric viewpoint]. Hiller E Z Arztl Fortbild (Jena); 1990; 84(6):239-41. PubMed ID: 2197824 [No Abstract] [Full Text] [Related]
32. Monitoring clinical trials. Sharples K; Fleming TR; MacMahon S; Moore A; Reid I; Scoggins B N Z Med J; 1998 Aug; 111(1072):322-5. PubMed ID: 9765633 [No Abstract] [Full Text] [Related]
33. Guinea-pigging: healthy human subjects for drug safety trials are in demand. But is it a living? Elliott C New Yorker; 2008 Jan; ():36-41. PubMed ID: 18265451 [No Abstract] [Full Text] [Related]
34. Ethics of clinical trials in human. Phaosavasdi S; Taneepanichskul S; Tannirandorn Y; Karnjanapitak A; Pruksapong C; Kullavanijaya P J Med Assoc Thai; 2002 Dec; 85(12):1317-20. PubMed ID: 12678171 [No Abstract] [Full Text] [Related]
35. Factors contributing to failed trials of new agents: can technology prevent some problems? Greist JH; Mundt JC; Kobak K J Clin Psychiatry; 2002; 63 Suppl 2():8-13. PubMed ID: 15453008 [TBL] [Abstract][Full Text] [Related]
37. Ethical problems in clinical trials concerning minimal residual tumors. Dion S; Reizenstein P Suppl J Med Oncol Tumor Pharmacother; 1988; 1():99-102. PubMed ID: 3074231 [No Abstract] [Full Text] [Related]
38. Ethical problems in clinical trials concerning minimal residual tumors. Dion S; Reizenstein P Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):99-102. PubMed ID: 2743535 [No Abstract] [Full Text] [Related]
39. Legal and ethical issues associated with patient recruitment in clinical trials: the case of competitive enrolment. Caulfield T Health Law Rev; 2005; 13(2-3):58-61. PubMed ID: 16459415 [No Abstract] [Full Text] [Related]
40. Conducting health research with vulnerable women: issues and strategies. Heaman M Can J Nurs Res; 2001 Dec; 33(3):81-6. PubMed ID: 11845625 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]